当前位置:首页 - 行情中心 - 东亚药业(605177) - 财务分析 - 资产负债表

东亚药业

(605177)

  

流通市值:30.67亿  总市值:30.67亿
流通股本:1.14亿   总股本:1.14亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金676,122,002.01711,124,397.81966,622,139.54406,310,639.66
应收票据及应收账款216,298,957.63140,782,808.64182,316,396.08169,837,385.42
应收账款216,298,957.63140,782,808.64182,316,396.08169,837,385.42
应收款项融资72,149,401.4468,805,393.1842,114,880.5642,977,816.92
预付款项5,963,500.535,636,911.88,242,706.296,599,053.41
其他应收款合计1,830,334.891,445,426.733,765,947.113,788,362.25
存货595,135,979.13621,057,626.76592,372,964.49543,010,677.11
一年内到期的非流动资产22,319,395.78177,903,035.87176,279,619.09174,656,202.31
其他流动资产23,406,054.2820,302,253.9213,409,293.7312,732,200.46
流动资产平衡项目0000
流动资产合计1,613,225,625.691,747,057,854.712,015,123,946.891,384,912,337.54
非流动资产:
其他权益工具投资10,500,00010,500,00010,500,00010,000,000
投资性房地产2,985.562,985.562,985.562,985.56
固定资产1,035,175,215.551,043,171,499.99880,343,859.73895,802,520.2
在建工程361,763,143.65296,553,636.17368,486,444.12247,345,153
使用权资产11,028,009.3912,128,542.213,230,545.7612,400,874.57
无形资产61,275,709.9661,853,613.9862,431,518.1762,470,618.6
开发支出4,192,890.57367,200367,200367,200
长期待摊费用21,641,436.310,449,984.4610,627,941.110,391,062.87
递延所得税资产13,741,741.1112,530,436.3312,975,510.2211,519,374.78
其他非流动资产258,767,700.23148,729,548.428,623,467.1513,505,419.28
非流动资产平衡项目0000
非流动资产合计1,778,088,832.321,596,287,447.111,367,589,471.811,263,805,208.86
资产平衡项目0000
资产总计3,391,314,458.013,343,345,301.823,382,713,418.72,648,717,546.4
流动负债:
短期借款130,122,238.88120,065,999.99107,826,319.82157,792,986.49
应付票据及应付账款479,340,024.45520,118,365.78513,960,318.4445,045,949.89
其中:应付票据155,147,150239,129,400220,964,000147,544,000
应付账款324,192,874.45280,988,965.78292,996,318.4297,501,949.89
合同负债2,569,872.043,232,163.863,770,254.635,261,818.41
应付职工薪酬17,582,744.5632,242,889.3626,295,012.1821,904,489.27
应交税费13,939,956.8815,727,153.0712,948,354.329,031,312.23
其他应付款合计1,190,929.022,779,736.824,441,218.694,091,151.17
应付股利-437,500--
一年内到期的非流动负债3,646,217.953,815,523.254,135,026.773,703,607.9
其他流动负债308,539.7965,385.95431,374.47533,938.96
流动负债平衡项目0000
流动负债合计648,700,523.57698,047,218.08673,807,879.28647,365,254.32
非流动负债:
长期借款60,000,000-87,500,00080,500,000
应付债券583,146,844.78576,428,842.89512,010,187.11-
租赁负债6,441,786.386,616,012.319,203,676.788,081,715.68
预计负债1,022,213.83318,601.89756,018.86777,116.5
递延收益76,600,586.5846,201,691.6647,918,934.5950,286,608.54
递延所得税负债389,697.24459,783.24236,519.02250,579.68
非流动负债平衡项目0000
非流动负债合计727,601,128.81630,024,931.99657,625,336.36139,896,020.4
负债平衡项目0000
负债合计1,376,301,652.381,328,072,150.071,331,433,215.64787,261,274.72
所有者权益(或股东权益):
实收资本(或股本)113,600,920113,600,000113,600,000113,600,000
其他权益工具116,778,509.21116,782,401.96176,336,250.76-
资本公积1,128,683,661.081,128,661,441.281,128,661,441.281,128,661,441.28
减:库存股55,003,293.9430,002,002.7317,463,733.52-
其他综合收益418,781.05-63,913.57-482,694.62-482,694.62
盈余公积43,009,136.6243,009,136.6238,251,451.9438,251,451.94
未分配利润667,525,091.61643,286,088.19612,377,487.22581,426,073.08
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计2,015,012,805.632,015,273,151.752,051,280,203.061,861,456,271.68
股东权益平衡项目0000
股东权益合计2,015,012,805.632,015,273,151.752,051,280,203.061,861,456,271.68
负债和股东权益合计3,391,314,458.013,343,345,301.823,382,713,418.72,648,717,546.4
公告日期2024-04-302024-04-242023-10-312023-08-11
审计意见(境内)标准无保留意见
TOP↑